Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Chimerix nets $107.4mm in IPO

Executive Summary

Oral antivirals developer Chimerix Inc. has netted $107.4mm through its initial public offering of 8.4mm common shares (including the overallotment) at $14 each. The company originally planned to sell 6.1mm shares between $13 and $15.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies